Fresh Tracks Therapeutics Inc Stock Ownership - Who owns Fresh Tracks Therapeutics?

Insider buying vs selling

Have Fresh Tracks Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when FRTX insiders and whales buy or sell their stock.

FRTX Shareholders

What type of owners hold Fresh Tracks Therapeutics Inc stock?
James R. Singer316.19%18,675,667$10.81MInsider
Austin W. Greenhouse David M. Marxe208.53%12,316,695$7.13MInsider
Armistice Capital LLC73.48%4,340,000$2.51MInsider
Vsciences Investments Pte Ltd68.32%4,035,424$2.34MInsider
Anges Mg Inc34.85%2,058,528$1.19MInsider
Dennison T. Veru17.45%1,030,840$596.86kInsider
Reginald L. Hardy12.96%765,285$443.10kInsider
Robert Busard Brown5.36%316,659$183.35kInsider
Igor Bilinsky3.28%193,798$112.21kInsider
Jill Marie Broadfoot2.47%145,649$84.33kInsider

1 of 3

FRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNAZ5.79%94.21%Net Buying
BXRX1.22%10.35%Net Buying

Fresh Tracks Therapeutics Stock Ownership FAQ

Who owns Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics (NASDAQ: FRTX) is owned by 2.48% institutional shareholders, 758.89% Fresh Tracks Therapeutics insiders, and 0.00% retail investors. James R. Singer is the largest individual Fresh Tracks Therapeutics shareholder, owning 18.68M shares representing 316.19% of the company. James R. Singer's Fresh Tracks Therapeutics shares are currently valued at $11.04M.

If you're new to stock investing, here's how to buy Fresh Tracks Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.